| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0014 | 1 |